Industry News (Joint Venture)
Research Collaboration for Cancer Gene Therapy Announced
Published in Gene Therapy Weekly, August 30th, 1999
Under the agreement, EntreMed's angiostatin and endostatin genes will be combined with Cell Genesys' proprietary adenoviral and adeno-associated viral (AAV) gene delivery systems in preclinical studies designed to assess whether the gene therapy can treat tumors by inhibiting their blood supply. The two companies will consider a potential business relationship based on the results of the studies performed under this collaboration.
Angiostatin and endostatin are...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (1999-08-30)
More Articles from Gene Therapy Weekly
- Cancer Gene Therapy
PTEN Gene Transfer Sensitizes Tumor to Radiation - Allergy Immunotherapy
Cow-Derived Lipocalin Allergen Has Fewer Side Effects - Drug Resistance (M. tuberculosis)
Rifampicin Resistance Examined Genetically - Obesity (Treatment)
Will Gene Therapy Help Solve Obesity Problems? - Cardiology
Expression Patterns of Endothelial Growth Factor Receptors - Gene Transmission
HTLV-I tax Sequences Missing in Population of Blood Donors - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
